2020

Journal Articles- Refereed

W Cui, F Franchini, M Alexander, A Officer, HL Wong, M IJzerman, J Desai, .... Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer. Lung Cancer 146, 310-317

K Degeling, HL Wong, H Koffijberg, A Jalali, J Shapiro, S Kosmider, ... M IJzerman. Simulating progression-free and overall survival for first-line doublet chemotherapy with or without bevacizumab in metastatic colorectal cancer patients based on real-world … Pharmacoeconomics 38 (11), 1263-1275

K Degeling, MJ IJzerman, MS Lavieri, M Strong, H Koffijberg. Introduction to metamodeling for reducing computational burden of advanced analyses with health economic models: a structured overview of metamodeling methods in a 6-step Application Process. Medical Decision Making 40 (3), 348-363

Maarten J IJzerman, Freek Anne van Delft, Hendrik Koffijberg, Valesca P Retel, Michel van den Heuvel. The validity and predictive value of blood-based biomarkers in prediction of response in the treatment of non-small cell lung cancer: A systematic review. Cancers 2020, 12(5), 1120.

E Faulkner, AP Holtorf, CY Liu, H Lin, E Biltaj, D Brixner… M J IJzerman, K Payne. Being precise about precision medicine: what should value frameworks incorporate to address precision medicine? A report of the personalized precision medicine special interest group - Value in Health, 2020.

G Chazan, F Franchini, M Alexander, S Banerjee… M J IJzerman, B Solomon. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. ESMO open, 2020.